View in EDS

Efficacy and safety of trabectedin or dacarbazine in patients with advanced uterine leiomyosarcoma after failure of anthracycline-based chemotherapy: Subgroup analysis of a phase 3, randomized clinical trial.

Saved in:
Bibliographic Details
Title: Efficacy and safety of trabectedin or dacarbazine in patients with advanced uterine leiomyosarcoma after failure of anthracycline-based chemotherapy: Subgroup analysis of a phase 3, randomized clinical trial.
Authors: Hensley, Martee L.1 gynbreast@mskcc.org, Patel, Shreyaskumar R.2 spatel@mdanderson.org, von Mehren, Margaret3 Margaret.vonmehren@fccc.edu, Ganjoo, Kristen4 kganjoo@stanford.edu, Jones, Robin L.5 robin.jones4@nhs.net, Staddon, Arthur6 arthurstaddon@pennoncology.com, Rushing, Daniel7 drushing@iupui.edu, Milhem, Mohammed8 mohammed-milhem@uiowa.edu, Monk, Bradley9 bradley.monk@usoncology.com, Wang, George10 GWang14@its.jnj.com, McCarthy, Sharon10 smccar15@ITS.JNJ.com, Knoblauch, Roland E.10 RKnoblau@its.jnj.com, Parekh, Trilok V.10 TParekh1@ITS.JNJ.COM, Maki, Robert G.11 RMaki@northwell.edu, Demetri, George D.12 gdemetri@partners.org
Source: Gynecologic Oncology. Sep2017, Vol. 146 Issue 3, p531-537. 7p.
Database: Academic Search Ultimate
Description
ISSN:00908258
DOI:10.1016/j.ygyno.2017.06.018